Kathrin Schumann

 

Position: Post-doctoral Fellow

emailkathrin.schumann [at] UCSF.edu

I grew up and studied Biochemistry in Germany. During my diploma and PhD thesis in Michael Sixt’s lab at the Max Planck Institute of Biochemistry near Munich I analyzed how the presenting mode of chemokines influences dendritic cell migration. After my PhD, I decided to gain experience in translational aspects of research and drug development. I joined the Novartis Postdoc Program in Basel, Switzerland, working within the autoimmune disease area. Beginning of March 2014 I am back in academia as a joint postdoc in the labs of Alex Marson and Jeffrey Bluestone. I am looking forward to learn more about regulatory circuits in T cells and to live in San Francisco…


Discovery of stimulation-responsive immune enhancers with CRISPR activation
Simeonov DR, Gowen BG, Boontanrart M, Roth TL, Gagnon JD, Mumbach MR, Satpathy AT, Lee Y, Bray NL, Chan AY, Lituiev DS, Nguyen ML, Gate RE, Subramaniam M, Li Z, Woo JM, Mitros T, Ray GJ, Curie GL, Naddaf N, Chu JS, Ma H, Boyer E, Van Gool F, Huang H, Liu R, Tobin VR, Schumann K, Daly MJ, Farh KK, Ansel KM, Ye CJ, Greenleaf WJ, Anderson MS, Bluestone JA, Chang HY, Corn JE, Marson A. Nature. 549; 111-115 (2017)

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Rupp LJ, Schumann K, Roybal KT, Gate RE, Ye CJ, Lim WA, Marson A. Scientific Reports. (2017)

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B, Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, Piechocka-Trocha A, Krogan NJ, Marson A, Sabatini DM, Lander ES, Hacohen N, Walker BD. Nature Genetics. (2017).

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human Cells.
Hulquist J*, Schumann K*, Woo JM, Manganaro L, McGregor MJ, Doudna J, Simon V, Krogan NJ, Marson A. Cell Reports. (2016).

Generation of Knock-in Primary Human T Cells Using Cas9 Ribonucleoproteins.
Schumamn K*, Lin S*, Boyer E, Simeonov DR, Subramaniam M, Gate RE, Haliburton GE, Ye CJ, Bluestone JA, Doudna JA, Marson A. PNAS. (2015).